Skip to main content
. 2022 Oct 19;13:981817. doi: 10.3389/fphar.2022.981817

FIGURE 6.

FIGURE 6

CBD reduces hepatic inflammation induced by CCl4. (A) Representative images of immunostaining for F4/80 (macrophage-specific marker; upper panel) and CD3 (lymphocyte-specific marker; bottom panel) from control, CCl4-vehicle, and CCl4 + CBD mice. Scale bars represent 100 μm. (B) Quantification of (percentage of total liver area) for F4/80 and CD3 (left and right panel respectively). Values are expressed as mean ± SEM (n = 6 animals per group). ***p < 0.001 vs. control group; ### p < 0.001 vs. CCl4 group (ANOVA followed by Tukey’s test).